The user wants me to evaluate the earnings call transcript against two gates. Let me analyze carefully. **GATE 1 — ORIGINAL SIGNAL** I need to find a positive, current development that management presents as genuinely going well, and where the Q&A produces MORE concrete operating detail than the prepared remarks. Let me look at the positive developments mentioned: 1. Sotyktu launch - going well, 9,500 script equivalents, mid-30s share of oral market 2. Opdualag - $117M sales, 20%+ market share in first-line melanoma 3. Camzyos - $29M, 2,700 patients in hub, 1,500 on commercial drug 4. Cell therapy (Abecma, Breyanzi) - growing 5. Reblozyl - $206M, growing 33% Let me check the Q&A for each: **Sotyktu**: In the Q&A, Seamus Fernandez asks about Sotyktu free drug dynamics and when payers will switch. Chris Boerner responds about the launch going well, 9,500 TRx equivalents, new patient enrollments up ~40% quarter-over-quarter, focus on pulling forward access decisions into this year, most commercial drug coming from open plans, 2024 as the point for substantive market access changes. This is somewhat additive but mostly repeats the prepared remarks (9,500 scripts was in prepared remarks). The new detail is the 40% quarter-over-quarter new patient enrollment growth and the timing of market access changes. But is this substantially more detail? It's somewhat additive but not deeply so. **Camzyos**: In the Q&A, the analyst asks about REMS certification being a gating factor. Chris Boerner responds with: 25% increase in HCPs REMS certified, now ~3,250, vast majority from top-tier accounts, targeting ~500 accounts at launch, utilization in excess of 90% in highest volume accounts, expanded the Eliquis cardiovascular team to target beyond initial 500 accounts, 50% increase in patients coming in for enrollment in Q1 vs Q4. This IS quite additive — new specifics about REMS certification numbers, account targeting, utilization rates, team expansion, enrollment increases. This is concrete operating detail that wasn't in the prepared remarks. **Opdualag**: Analyst asks about market share slowing. Chris Boerner responds about 65% of utilization from PD-1 monotherapy, monotherapy still 15-20% in first-line, NCCN update removing BRAF inhibitors as preferred treatment, all preferred options now dual IO. This is somewhat additive.
Bristol-Myers Squibb Company
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Are there more than eight analyst questioners?
- Does the operator announce more than five questioners?
- Does the operator announce more than ten questioners in the Q&A?
- Is there a questioner from an investment bank other than the first three analysts who ask questions?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q2 2026 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question the executive answers with a question back to the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use "historically" or "traditionally" while defending a current practice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question spanning more than five sentences?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer a question personally after another executive initially responds?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "if you look at" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst preface a question by summarizing the company's stated results?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the word "obviously" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "guidance" in the same sentence as a specific number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst say "congrats" or "congratulations" to management?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst name two or more executives when asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "outperform," "outperformance," or "beat" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "with that" as a transition phrase?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "moving to" or "turning to" when changing topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "operator" aloud during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "as you know" to introduce a claim?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker apologize without attaching a fix to the apology?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a request to move the call along or to the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive answer a question with another question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive describe a competitor with anything resembling respect?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator announce more than ten questioners in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "kind of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question include the word "color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "if I may" or "if you don't mind"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst use the word "clarification" or "clarify" in a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the phrase "color on" or "some color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "let me" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "aggressive" or "aggressively" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "for the benefit of" or "just to remind" when restating context?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "early days"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "journey" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an apology offered to a specific analyst by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be honest" or "frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does someone use a personal anecdote rather than a metric to justify confidence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "growth" appear at least ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask about capital allocation or buybacks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the word "strong" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we're seeing" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "opportunity" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the word "confident" or "confidence" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "moving forward" or "go forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention a specific number of stores, locations, or markets?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "folks"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we believe"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator use the phrase "next question" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst mention a specific percentage figure in their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does at least one analyst ask a question about margins or costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO answer the majority of analyst questions personally?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question begin with the words "can you" or "could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the phrase "if you look at" during the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO answer at least one question without the CEO speaking first?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question containing an explicit comparison to a competitor company?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "guidance" appear at least five times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "I think" at least three times within a single answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive's answer exceed 300 words in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO answer the first analyst question personally?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "obviously" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "So" as the first word?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "if I may" or "if I could" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "let me" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question contain the word "specifically"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "momentum" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management mention "margin" or "margins" in prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "definitely" used by any speaker?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "leverage" as a verb at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "that said" or "having said that" to introduce a caveat?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "great question" at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we remain confident" or "we are confident"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "thank you" immediately after finishing an answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a specific dollar figure greater than one billion?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question contain the word "curious"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "obviously" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a follow-up in the same turn after their first answer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask about a specific geographic region or market?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "take your question" or "take the question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst introduce themselves by name before asking their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "including" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive reference "our team" or "the team" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "with that, I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO use the phrase "capital allocation"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a two-part question containing the word "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone ask a follow-up question in the same turn after their first question is answered?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone answer "yes" or "no" as the first word of a response?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "thank you" at least ten times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "if you look at" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a peer company's results or valuation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "tailwind" or "tailwinds"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "investments" appear in the context of margins or costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone mention "FX" or "foreign exchange"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "efficiency" or "productivity" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "great question" or "thanks for the question"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as we said last quarter" or reference a prior call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts by name at any point after a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we'll take that offline" or offer to follow up after the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the word "committed" regarding a target?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "the vast majority"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is an analyst's question answered with "great question" or similar?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question that includes a reference to a specific dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES A single question receives answers from two different executives.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "obviously"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive defer a question to another executive by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Someone uses the word "honestly," "frankly," or "to be clear."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "ecosystem" or "platform" without a number attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the transcript contain the word "certainly" three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst reference a competitor by name during their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does a speaker say "let me" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The transcript contains an apology unrelated to financial results.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The phrase "as you know" appears at least twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "challenge" or "challenges" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "thank you" to the analyst before answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "great question" or similar praise of a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES The final question is answered noticeably shorter than the opening ones.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the transcript contain a sentence that begins with "What I would say is"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question mention a specific percentage or dollar figure?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO personally answer more questions than any other executive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "clearly" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "leverage" appear as a verb at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's first name get used by an executive when thanking them?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator announce more than five questioners?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are there more than ten analyst questions in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator use the phrase "our next question comes from" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "we are not going to comment on" or equivalent refusal language?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Executive corrects an analyst's premise.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO personally answer more than half of the analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive uses the word "excited" more than twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "we said" when recalling prior statements?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst begin their turn with "thanks" or "thank you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst address a question to two or more executives by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we feel" rather than "we believe" or "we think"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "capital" appear in at least three different speakers' turns?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive use the phrase "over time" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "leverage" (financial or metaphorical)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the word "automation" or "productivity" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "leverage" or "leveraging" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "a number of" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "best-in-class" or "industry-leading"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "momentum" appear at least twice in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst's question include the phrase "just to clarify"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "the team" appear at least twice in management remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "so clearly" or "quite frankly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the phrase "we believe" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker says "we don't guide" on anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "quarter" at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts for their questions at any point during Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Speaker admits being surprised by anything.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "stay tuned" or "more to come"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive mentions a hobby or personal anecdote.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "our team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we remain" followed by an adjective?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management thank analysts by name when responding?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the word "flexibility" or "flexible" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "takeaway," "take out," or "take rate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Analyst compliments the team before asking a question.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst reference the CEO or CFO by first name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "obviously" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "pipeline" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question starting with "just"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question go to a named executive other than the CEO or CFO?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "to be clear" or "let me be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone mention a competitor by name without being prompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question explicitly reference the company's prior guidance or outlook?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "invest" or "investment" appear at least five times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst flatter management within their first sentence of speaking?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "underlying" to modify a business metric?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive answer a question by citing a competitor's actions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenges" appear more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO begin an answer with "look" or "listen"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive name a specific competitor during the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenges" appear at least three times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive mention a specific number of percentage points when discussing market share?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker correct a figure they themselves just stated?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO mention their own tenure or years of experience unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the team" when taking ownership would be natural?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone blame weather, holidays, or calendar quirks unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone cite a personal anecdote involving a customer conversation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a little bit"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the CFO the speaker for at least one analyst question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "dividend" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the word "invest" or "investment" used more than twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "invest" or "investment" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone cite a percentage of revenue from a specific segment?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenge" or "challenging" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone describe cutting discretionary spending like travel or hiring?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "year over year" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention selling assets, real estate, or equipment to raise cash?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "our customers" rather than naming a customer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "we remain confident" or similar?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "with that" or "that said" to pivot?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive open their first answer by thanking the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "core" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's turn contain the word "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are there more than eight analyst questioners?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question include a percentage figure?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question contain the word "guidance"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "if you look at"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO personally answer the first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "tailwind" or "tailwinds"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management use the phrase "balance sheet" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator say "our next question" two or more times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst preface a question with "quick" or "quickly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive state a specific numeric percentage when answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "guidance" appear in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "strong" appear more than five times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you" appear more than ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "guidance" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask about capital allocation or share repurchases?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenge" or "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a personal, warm, or congratulatory question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question the prepared remarks already answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear at least twenty times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any single analyst ask more than two questions during the whole call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the word "headwinds" or "tailwinds" used?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "confidence" or "confident" spoken by any executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "coming back" or "circling back" to take a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we believe" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "robust"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "if you will" or "so to speak"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "appreciate" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "at the end of the day"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive use the phrase "our team"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we're pleased" or "I'm pleased"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" or "exciting" used by management at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question begin with "Can you" or "Could you"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quick" or "quickly" appear in three or more analyst questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask for guidance on a metric management did not offer unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst use the word "clarify" or "clarification"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "obviously" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management refer to a prior call or prior quarter's commentary when answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "actually" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive begin an answer with "Look," or "So,"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" or "challenges" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator run out of queued questions and close early?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst apologize or preface with "sorry" before asking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "excited" used by the CEO more than the word "confident"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear more than five times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "tailwind" or "headwind" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's question begin with a compliment or congratulation?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst apologize before or during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Are there more questions about revenue than about costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we're not going to" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quarter" appear at least 20 times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a mention of "FX," "currency," or "foreign exchange"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive say "that's right" or "that's correct" to an analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "leverage" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "great question" or thank the analyst before answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone attribute results to "the team" rather than to strategy?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst begin their question with "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst thank management at the end of their turn?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe the future with "We believe" more than "We expect"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "momentum" used without a stated metric attached to it?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "solid" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there an analogy to a machine, engine, or flywheel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "base case" or "scenario" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "to your point" or "as you mentioned" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "thank you" more than three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management mention a specific competitor by name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "the team" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "fundamentally" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any single speaker say "right?" as a tag question at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "on a consistent basis" or "consistently"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "strategic" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "resilient" or "resilience" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator mention a queue or "next question" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "if you look at" before citing a number?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "last question" or "final question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "clearly" appear anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO mention a specific percentage greater than ten?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "confident" appear in any executive's remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO use the word "incredibly" at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "to your point" when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "with that" to transition between speakers or topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "transformation" or "transformational" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst identify themselves with a two-part introduction (name and firm)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "talent" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a supplier or vendor mentioned by name at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on BMY calls. Open a question to read the model's original reasoning.
NO Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development — compa
Original model output from the research archive. It may be verbose or include the model's working notes.
The task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. Answer with exactly YES or NO.
The task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. YES NO (GATE 2 fails because the lung business momentum is explicitly conditioned on the external approval of the Merck combo and the competitive landscape; the primary engine is therefore not fully company-controlled.
NO Already spoken for downstream: customers are buying to fulfill business they have already secured
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that customers are buying from the company to serve business those customers have already secured on their own side. The transcript is about Bristol-Myers Squibb, a pharmaceutical company. The customers are likely patients, physicians, or healthcare systems. The question asks if management describes that the demand behind what the company sells is already committed on the far side of its customers. For a pharma, this could be like patients already diagnosed, or insurance coverage, or government reimbursement decisions, or contracts with payers. But the transcript focuses on Opdivo, Yervoy, Eliquis, etc. Management discusses reimbursement, price negotiations, launches, etc. For example, they mention completing price negotiations for France and Germany, which led to revenue recognition. That suggests that once reimbursement is secured, sales follow. But is that "customers' secured business"? The customers are patients or physicians, but the reimbursement is a form of funding or approval. However, the question is about the customers having already secured business on their own side. For pharma, the "customer" might be the patient or the healthcare provider, but the demand is driven by disease prevalence, not necessarily a secured contract. Management talks about "access and reimbursement" as a driver. They say "our teams have done a great job with access and reimbursement." That implies that once reimbursement is in place, sales occur. But is that a commitment already in place? Possibly, but it's more about market access than customers having secured their own business. The question specifically asks: "does management describe that what is pulling the company's current or incoming business is not its customers' hopes, plans, or moods, but commitments already in place one step further along the chain: work the customers have already won, sales they have already made, projects already awarded or underway, programs already launched, or funds already raised, appropriated, or earmarked for the purpose the company serves?" For a pharma, the customers are patients, but patients don't "win" business. The chain might be: patients have a disease, they need treatment. But that's not a secured commitment. Alternatively, the customers could be hospitals or clinics that have contracts or budgets. Management doesn't describe that.
NO Betting on a claim they haven't proven yet: management stakes the company on a specific quantitative outcome it says it
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management stakes the company's near-term future on ONE SPECIFIC, MEASURABLE PERFORMANCE CLAIM THAT HAS NOT YET BEEN PROVEN AT SCALE — a concrete assertion about what its product, asset, process, operation, or offering WILL ACTUALLY ACHIEVE when run in the real world — and whether management is already spending the company's own money and capacity as though that claim were true, with proof arriving within roughly the coming year. Let me examine the transcript for such a claim. The transcript discusses: - Opdivo/Yervoy combination in lung cancer - CheckMate-227 trial - Various commercial expectations - Financial guidance Key candidates for performance claims: 1. The Opdivo/Yervoy combination in first-line lung cancer — management says they are "committed" to it, but they explicitly refuse to provide specific details about the data or the program. They don't assert a specific performance level. They say "we believe through our broad development program we have an opportunity to play a meaningful role" — this is vague and directional, not a specific measurable claim. 2. CheckMate-227 — management says they have "optionality built in" and that they can't provide details. No specific performance claim is made about what the trial will show. 3. Commercial claims about Opdivo growth — these are about sales, revenue, market share, which the question explicitly excludes ("NO if management's forward claims are about volume sold, demand, revenue, earnings, margins, or market share rather than about how well something will physically or operationally perform"). 4. The IDO program — Francis says "we would hope, if it's good data, to move the mechanism into registration" — this is aspirational, not a specific claim. 5. Eliquis, Orencia — these are already established at scale, so nothing remains to be proven. 6. The lung cancer program broadly — management says they have four combination front-line lung studies ongoing, but they don't assert a specific performance level (e.g., a specific PFS or OS benefit, a specific response rate). Looking for a specific, measurable, unproven-at-scale performance claim: - Management does not state a specific clinical result the combination will achieve (no specific hazard ratio, response rate, survival benefit). - Management does not state a specific operational performance (yield, throughput, cost per unit).
NO Proof-point cadence: the last promised marker just landed, and the next one is already on the clock
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management presents a live, checkable sequence of proof points with both a marker just delivered and a next marker named and near. The transcript: management discusses 2016 results, Opdivo sales, regulatory updates, etc. They mention specific events: completing price negotiations for France and Germany, which resulted in revenue recognition. That could be a marker just delivered. They also mention expected approvals: bladder approval expected, and they mention the potential entry of Keytruda/chemo combo in May, which they assume. But is that a next marker on the same path? They also mention data readouts for various programs. But the question asks for a coherent posture where management presents a sequence: last checkpoint cleared, next checkpoint on the clock. For example, they might say "we completed X, and next we will do Y by Z time." Here, they mention completing price negotiations (a concrete step) and then they mention expected approvals and data readouts. However, the next steps are often vague or contingent. For instance, they say "expected bladder approval" but not a specific date? They say "the expected bladder approval" but no timing. They mention data readouts for IDO, GITR, LAG-3 but no specific timing. They mention CheckMate-227 but are cryptic. The essence: management must present a specific operational checkpoint just delivered and a specific near-term next step on the same path. The price negotiations completion is a checkpoint, but what is the next step on that same path? Perhaps they say "we expect to see continued growth internationally in 2017" but that's not a specific next step. They also mention "we completed price negotiations for France and Germany" and then "Overall, I expect to see continued growth internationally in 2017." That's not a named next marker with timing. They also mention "the expected bladder approval" but no timing. They mention "we expect to see important early data readouts, including IDO, GITR, and LAG-3" but no timing. The question requires that the next step is anchored in the near term with at least approximate timing. They do mention "Later this year, we expect early data in house from assets in systemic lupus, NASH, and psoriasis." That's a specific timing (later this year) but is that on the same path as a just-delivered marker? The just-delivered marker might be something else.
NO Whole company hinges on one thing already in motion, and management is visibly betting the enterprise on it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES or NO. Need analyze transcript. Need determine if management speaks as though fate of entire company riding on one identifiable thing already in motion, small/unproven relative to expected. Need use only transcript. Let's parse. Company Bristol-Myers Squibb. Call Q4 2016. Topics: Opdivo, lung cancer program, I-O. Management discusses broad priorities. Need see if single center of gravity? They talk about lung cancer program, Opdivo/Yervoy combo, immuno-oncology. But also Eliquis, Orencia, pipeline. Need assess. Question asks: "On this call, does management speak as though THE FATE OF THE ENTIRE COMPANY IS RIDING ON ONE IDENTIFIABLE THING THAT IS ALREADY IN MOTION — that is, is there a single, nameable undertaking, asset, relationship, product, program, or market position that management treats as the thing that will determine what this company becomes, where that thing is (a) already real and moving now, and (b) still small or unproven relative to what management believes it will be?" Need answer YES if all three: single center of gravity, already in motion, economics mostly ahead. NO if broad balanced business. Let's read transcript carefully. Giovanni opening: "2016 was a year of strong operational performance... 17% growth in sales and 41% growth in non-GAAP earnings. While I will provide some comments on 2016 and my thoughts on 2017... Knowing that last week's regulatory update is on your minds, I will start by providing my perspective on our lung cancer program." Then discusses lung cancer program: "We have a broad front-line lung cancer program which we expanded and strengthened over the last several months. We have four combination front-line lung studies that are ongoing. These studies are designed with the optionality we build into all of our studies. We are committed to the development of the combination of Yervoy plus Opdivo. As you know, the competitive landscape in this space has changed over the last 9 to 12 months, and it could very well change again based on future data readouts. We believe through our broad development program we have an opportunity to play a meaningful role in the treatment of patients in the first-line lung cancer setting. And with this in mind, our R&D team is focused and well-resourced in front-line lung and is constantly looking for ways to strengthen our program and bring forward new treatments.
NO The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Is there a specific negative outcome that investors/analysts/market are worried about, and does management push back with current, already-observed evidence showing it's not materializing? We need to identify a specific fear that is live on the call, and management's response citing observed behavior. From the transcript, there are several worries. The most prominent is about Opdivo's position in lung cancer, especially after the regulatory update and competition from Keytruda/chemo combo. Analysts ask about the impact of potential approval of Keytruda/chemo combo, and management acknowledges that they assume that approval and its impact. But is there a specific fear that management pushes back with observed evidence? For example, the fear that Opdivo will lose share in second-line lung. Management says they exited 2016 at 40% share, gave up 10 points due to Tecentriq, but they are defending. That is observed evidence. Also, they mention that in the U.S., they expect Opdivo to be roughly flat, but they have growth in international. However, the question is about a specific negative outcome that investors are worried about, and management counters with observed evidence that it's not materializing. Another worry: the decline in hep C business due to competition from Epclusa. Management acknowledges that decline is accelerating, so that fear is materializing, so not a pushback. Another worry: the potential loss of Sprycel patent in Europe. Management says they feel confident, but that's not observed evidence. Another worry: the impact of the Keytruda/chemo combo on Opdivo's first-line lung sales. Management says they assume approval and that some non-promoted sales will go away, so they are not pushing back with evidence that it's not materializing; they are incorporating it. But there is a specific worry about the U.S. lung business facing competitive pressure. Management says they are defending, and they cite that they exited at 40% share, which is observed. Also, they mention that they regained market share in RCC during Q4. That is observed evidence. However, the question asks for a specific negative outcome that investors are worried about, and management pushes back with observed evidence showing it's not materializing. The clearest example might be the worry about Opdivo's U.S.
NO Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' trajectories. Let's analyze the transcript. The company is Bristol-Myers Squibb, a pharmaceutical company. The call discusses their products, especially Opdivo, Yervoy, Eliquis, etc. The "counterparties" in this context could be payers, healthcare systems, or perhaps partners like Pfizer for Eliquis. But the question is about management narrating what counterparties are doing and scaling. Looking at the transcript, management discusses their own commercial execution, their own R&D programs, their own pipeline. They talk about market dynamics, competition, and their own strategies. They mention international business, reimbursement negotiations, and uptake curves. However, they do not seem to be narrating the growth of specific counterparties as the driver of their own business. They talk about their own sales, their own market share, their own launches. They mention "we have assumed the approval of KEYNOTE-021" which is a competitor's product, but that's about competition, not about a counterparty they supply. The question specifically asks about counterparties that the company already supplies or serves, such as customers, partners, licensees, distributors, payers, operators, or programs. In the pharma context, perhaps they could be talking about payers like insurance companies or government programs, but they don't describe those entities' own expansion. They talk about reimbursement decisions, but that's more about access, not about the counterparty scaling. They also mention their partnership with Pfizer for Eliquis, but they don't narrate Pfizer's own growth as the driver; they talk about Eliquis sales and the profit share. Thus, management's forward account is primarily about their own actions, their own pipeline, their own commercial execution, and market conditions. They do not describe specific counterparties' own trajectories as the reason for their coming volume.
NO Running ahead of their own plan — and management has already acted on it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management indicates that some real, operating part of the business performed ahead of management's own prior expectation, plan, or timeline in the period just reported, and has the company already taken at least one concrete action in response to that favorable surprise. We need to look for management's own words about a favorable operating surprise, not just financial results versus guidance. Also, a concrete response already underway. Let's scan the transcript. Giovanni Caforio: "2016 was a year of strong operational performance for the company with 17% growth in sales and 41% growth in non-GAAP earnings." That's just results. Later, about Opdivo: "We recorded $1.3 billion of worldwide revenue for Opdivo in the quarter, reflecting continued strong execution across our markets. The successful outcome of price negotiations in both France and Germany resulted in $373 million of revenue recognition in the quarter, inclusive of approximately $250 million deferred from previous quarters." That's about revenue recognition, not necessarily operating surprise. Murdo Gordon: "Outside of the U.S., as reimbursement has come online and as final price negotiations have occurred, we've seen really nice uptake, and I would say uptake curves consistent with what we've seen historically in the U.S. So both in France and in Germany, the Opdivo business is performing well in melanoma and in lung." That's positive but not necessarily ahead of management's own expectations. Later, Murdo: "We exited 2016 at roughly a 40% share of second-line lung, which was in line with our expectations." So that was in line. What about the international business? "Our teams have done a great job with access and reimbursement. You've seen that in our full-year results." Not explicitly ahead. Look for phrases like "ahead of our plan", "exceeded our expectations", "faster than we anticipated", "stronger than we assumed". I don't see such explicit phrases. There is a mention of "we did see demand growth, although at a slowing rate." That's not ahead. Maybe about Eliquis? "Increased demand during the quarter for Eliquis was the primary driver for growth in the U.S." But no comparison to expectations. What about the response? Is there any concrete action taken because of a favorable surprise? For example, adding capacity, accelerating rollout, etc. I don't see any.
NO Upside surprise with durable, still-building causes
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: does management describe a clear positive step-up in the business in the just-reported period (Q4 2016) that came in meaningfully stronger than the company's own recent norm or its own prior expectations, AND does management attribute that strength mainly to durable, company-specific causes that are still in effect and still building? We need to look at the transcript. The call is about Q4 2016 results. Management discusses various aspects. Let's see if they describe a step-up. Giovanni Caforio: "2016 was a year of strong operational performance for the company with 17% growth in sales and 41% growth in non-GAAP earnings." That's for the full year, not necessarily a step-up in Q4. They talk about Opdivo, Eliquis, etc. But they also mention challenges: "our second-line business will face increasing competitive pressure in 2017" and "we expect Opdivo to grow globally, driven by our international business. In the U.S., we expect Opdivo will be roughly flat with the potential to show growth." So they are not describing a step-up in the recent period; they are describing a mixed outlook. They also mention "the potential for an earlier than expected entry of the Keytruda/chemo combo" which is a negative. They also mention "we have now stopped promotional activities for hep C in the U.S. and expect the decline to accelerate this year." So the virology business is declining. The question is about the just-reported period (Q4 2016). Did they report a step-up? They reported strong full-year growth, but for Q4, they mention Opdivo revenue of $1.3 billion, but they also say "In the U.S., we did see demand growth, although at a slowing rate." And "our sales of $715 million were roughly flat versus Q3." So not a step-up. They also mention "the successful outcome of price negotiations in both France and Germany resulted in $373 million of revenue recognition in the quarter, inclusive of approximately $250 million deferred from previous quarters." That is a one-time catch-up? Actually, it's recognition of deferred revenue, which is a one-time event. They also mention "inventory work-down" and "reversal of inventory build" for Yervoy. So there are some one-time items. Overall, the tone is cautious, with competitive pressures. They are not describing a clear step-up above their own recent norm.
NO The streak is alive: management narrates back-to-back quarters of the same improvement and shows this quarter extended i
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management presents the just-reported period as the latest step in an unbroken, still-running sequence of quarter-after-quarter improvement in the same part of the business, explicitly connecting this period to the immediately preceding period(s) as one continuing climb, with real current-period evidence. We need to look for management's own words that convey a named improvement that has repeated across consecutive periods, with chaining, real current evidence, and management treating the sequence as still running. The transcript is about Q4 2016 earnings. Management discusses various products. We need to find if any part of the business is described as improving sequentially quarter after quarter. Let's scan the transcript for phrases like "another quarter of growth", "fourth consecutive quarter", "improved again", "each quarter", etc. I see mentions of Opdivo, Eliquis, Yervoy, etc. But the overall tone is about challenges in lung cancer, competitive pressure, etc. Management talks about 2016 strong performance but also about 2017 guidance being revised down due to FX and Keytruda/chemo combo. Look for specific sequential improvement claims. For example, Murdo Gordon talks about Opdivo business in U.S. non-lung, but does he say it improved sequentially? He says "we continue to see very strong execution" but not necessarily sequential. Giovanni Caforio says "2016 was a year of strong operational performance" but that's annual, not sequential. Charlie Bancroft mentions "We recorded $1.3 billion of worldwide revenue for Opdivo in the quarter, reflecting continued strong execution across our markets." But no explicit sequential improvement. There is mention of "In the U.S., we did see demand growth, although at a slowing rate." That might be sequential? But not clear. Also, "Our sales of $715 million were roughly flat versus Q3" - that's not improvement. For Eliquis, "Increased demand during the quarter for Eliquis was the primary driver for growth in the U.S." But no sequential chaining. We need to find a specific part of the business where management explicitly says it improved again this quarter on top of previous quarters. For example, "another quarter of growth" or "our fourth consecutive quarter of..." I don't see such language. The transcript is more about defending positions, facing competition, and revising guidance.
NO Front, middle, and back of the business all improving at once, in management's own present-tense telling
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need evaluate transcript. Need determine if management's own account describes real, already-occurring improvement in all three zones simultaneously: front (new business arriving), middle (delivery/output), back (retention/committed forward). Need use only transcript. We need parse. Company Bristol-Myers Squibb Q4 2016. They discuss strong 2016 performance, 17% sales growth, 41% EPS growth. But question asks about just-reported period (Q4 2016) and whether management describes real improvement in all three zones at same time. Need identify concrete current activity. Let's examine transcript. Management highlights: Opdivo revenue $1.3B in quarter, strong execution. U.S. demand growth slowing, sales roughly flat vs Q3, inventory work-down. International growth, price negotiations France/Germany resulted $373M revenue recognition incl $250M deferred. Yervoy steady demand, sales down slightly due inventory reversal. Eliquis growth. Virology declining. 2017 guidance revised due FX and Keytruda/chemo. Need map zones: Front = new business coming in: new patients, new indications, launches, new approvals? They mention head-and-neck launch, expected bladder approval (not yet), international reimbursement. But "new business actually coming" in Q4? They mention "completed price negotiations for France and Germany" leading revenue recognition, but that's deferred revenue, not new. They mention "continued strong execution across markets." They mention "U.S. demand growth, although at a slowing rate." For Opdivo, sales roughly flat. For Eliquis, demand growth. For Yervoy steady demand. New business? Maybe new patients starting therapy? They don't give specific new starts. They mention "recently launched head-and-neck indication" - launch is new business? But no concrete numbers. "expected bladder approval" is future. "International business" growth due access/reimbursement. But is that new business arriving? They say "our teams have done a great job with access and reimbursement. You've seen that in our full-year results. Specifically in the quarter, we completed price negotiations for France and Germany." That is securing reimbursement, which allows sales, but not necessarily new orders. They recognized deferred revenue. Could be front? Hmm. Middle = delivery: actual sales, shipments, patients served. They report sales, revenue.
NO Selling into a customer's own emergency
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management describes the company's offerings as relieving a pressing, costly problem the customer is already living with right now. The transcript is about Bristol-Myers Squibb, a pharmaceutical company. They discuss Opdivo, Yervoy, Eliquis, etc. The context is oncology and other diseases. The question is whether the products are bought to relieve an active problem like a disease, which is a pressing problem. However, the question asks specifically about "a shortage, failure, deadline, penalty, safety or compliance exposure, staffing gap, outage, backlog, spoilage, loss, or other pain the customer is actively bleeding from." For a pharma company, the customer is the patient, and the pain is the disease. Management does describe that patients are being treated for cancer, etc. But does management frame it as an active emergency? They talk about treating patients, but the language is more about market share, growth, etc. They don't explicitly describe the patient's pain as a live emergency. They talk about "defending our position" and "competitive pressure." The question is about whether the purchase functions as relief from an active problem. In pharma, the product is indeed for a disease, but the transcript focuses on commercial dynamics, not on the patient's suffering. Management does mention "patients" but not in a way that conveys urgency or that they are bleeding. They talk about "unmet need" but that's generic. The question says: "Answer YES when management's own words convey... the company's offering sits on the relief side of somebody else's live emergency." Here, the emergency is the disease, but management doesn't describe it as such. They talk about "growth prospects," "market share," etc. They don't describe customers (patients) as facing a pressing problem that they must solve now. They do mention "defending our second-line position" but that's about competition. The question also says "NO if the offering is described mainly in terms of benefits, savings, productivity, better performance, or attractive returns for the customer." Here, they talk about "strong execution," "growth," etc. They don't describe the patient's pain. So likely NO. But let's check if there is any specific mention of patients' urgent needs. For example, they talk about "unmet need" but that's abstract. They mention "patients" in passing.
NO Growing out of the old self: management itself says the company has quietly become a different business, and the numbers
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Question asks: Does management convey that company today is running on different basis than reported results/reputation built on? Both halves: (1) change of basis already real; (2) management says record/perception lag change. Need use only transcript. Need decide. Let's parse. Bristol-Myers Q4 2016. Management discusses strong 2016, Opdivo growth, but lung cancer setback, competitive landscape. They talk about priorities. Do they describe company as now operating on different foundation? Maybe not. They mention "we are focused on broad set of priorities in oncology beyond lung cancer." They mention "we will build on strength of brands Eliquis and Orencia in near term. Longer term, advancing efforts to diversify portfolio with new pipeline agents..." That's future. They mention "we have 11 clinical stage I-O molecules" etc. But is there a change of basis already real? They talk about "we are committed to development of Yervoy plus Opdivo" and broad program. They don't say company has become different kind of business. They talk about 2016 strong performance, 2017 guidance. They mention "we have now stopped promotional activities for hep C in U.S. and expect decline to accelerate." That's a change in virology business, but not root change? They mention "our 2017 guidance takes account of continued declining contribution of virology and growth of Eliquis, offset by Opdivo." That's mix shift. But does management convey that reported results lag? They say "we expect Opdivo to grow globally, driven by international business. In U.S., Opdivo roughly flat..." Not really. Question asks specifically "THE COMPANY TODAY IS RUNNING ON A DIFFERENT BASIS THAN THE COMPANY ITS REPORTED RESULTS AND REPUTATION WERE BUILT ON" - management itself describes crossing into different kind of business. Need see if any statement like "we are now a different company" or "our results don't reflect new reality." They don't. They emphasize "strong operational performance" and "proud." They discuss "we are very focused on executing" etc. No. Potential nuance: They had patent litigation settlement with Merck, "strength of patents acknowledged." Not relevant. They mention "we have a broad front-line lung cancer program which we expanded and strengthened over last several months." That's change in R&D program, not business basis.
NO Trajectory bent upward recently, and management says the change has only started showing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management conveys recent upward bend and early. Need only transcript. Let's parse. Question asks: "Using ONLY supplied earnings call transcript... On this call, does management convey that the company's trajectory has RECENTLY BENT UPWARD — that within the last few quarters something real changed in how the business is performing, so that its current direction is meaningfully better than the path it was on before — AND does management indicate that this change is still early, with most of its effect not yet visible in the results being reported?" Need answer YES when both. Need be strict. We need evaluate transcript. Company Bristol-Myers Squibb Q4 2016. Management discusses 2016 strong operational performance: 17% sales growth, 41% non-GAAP EPS growth. But is there a recent bend upward? They had strong 2016. But question asks recent bend within last few quarters, contrast old path vs new. Did management describe something real changed? Let's examine. Giovanni opening: "2016 was a year of strong operational performance for the company with 17% growth in sales and 41% growth in non-GAAP earnings." That's continuing strong performance? Maybe not bend. They discuss Opdivo, international business, non-lung U.S., lung U.S. They mention "In 2016 we did a great job establishing Opdivo. We know our second-line business will face increasing competitive pressure in 2017..." Not upward bend. They mention "we announced last week positive resolution of patent litigation with Merck for PD-1... strength of patents acknowledged..." That's a legal event, not business trajectory. Charlie: "we delivered a very strong 2016. This was in spite of foreign exchange headwinds..." "Opdivo $1.3B worldwide revenue in quarter, reflecting continued strong execution." "In U.S., we did see demand growth, although at a slowing rate." "As we expected, U.S. lung market has started to become more competitive..." "Since we discussed 2017 expectations for Opdivo sales back in October, our outlook for the year has been affected by potential earlier entry of Keytruda/chemo combo. Taking this into account, we expect Opdivo to grow globally, driven by international business. In U.S., we expect Opdivo roughly flat..." This is not upward bend; it's downward revision. Yervoy steady. Eliquis growth. Virology decline.
NO Position doing the winning: current wins credited to a standing already held, with more arriving over it
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether management explains current business wins as flowing from a standing the company already holds, and whether more business is arriving over that same standing without a proportional new push. Looking at the transcript, management discusses various business areas. For Opdivo, they discuss defending second-line position, facing competitive pressure, and expecting flat U.S. sales. For international business, they discuss reimbursement and access gains. For Eliquis, they discuss growth. The key question is whether management credits current wins to a standing already held. Let me look for specific examples: 1. For Opdivo international: "our teams have done a great job with access and reimbursement" - this sounds like effort-based, not a standing. 2. For melanoma: "the combination regimen in melanoma" - they mention "our very competitive position in renal cancer" - but this seems more like describing a position rather than explaining wins flowing from it. 3. For Eliquis: "we are very pleased with what we are doing with Eliquis, which has been established as the leading AF brand globally" - this mentions an established position, but doesn't clearly explain current wins flowing from that standing. 4. For Opdivo in the U.S. non-lung: "2016 was a great year in the U.S., driven by the combination regimen in melanoma and our very competitive position in renal cancer" - again, this describes a position but doesn't clearly attribute current wins to it. The transcript doesn't seem to contain a clear statement where management says "customers choose us because of X standing we already hold, and more business is arriving over that same standing." Instead, management talks about defending positions, facing competition, and executing. For example, on Opdivo U.S. lung: "our teams are focused on defending our position" - this is effort-based, not standing-based. On international: "our teams have done a great job with access and reimbursement" - effort-based. The question requires BOTH halves: (1) an already-held standing is doing the winning, and (2) more is arriving over that same standing. I don't see this clearly articulated in the transcript. Management talks about positions and execution, but doesn't present a coherent causal story where a pre-existing standing is generating current wins with more flowing in. The answer is NO.
NO Bigger keys handed over: the work customers now entrust has outgrown the work the company historically received
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need determine if management describes company now being entrusted with materially larger/more central class of work than historically. Need parse. The question is about "engagements, projects, orders, mandates, roles" stepping up in scale/consequence. In transcript, Bristol-Myers Squibb is pharma. They discuss Opdivo, lung cancer, pipeline, commercial execution. Is there any statement about company being entrusted with larger class of work? Maybe not. They discuss "broad front-line lung cancer program" and "opportunity to play meaningful role" but not necessarily already visible? They discuss "we have four combination front-line lung studies" and "expanded and strengthened" program. But is that "being entrusted with materially larger or more central class of work"? Hmm. Need be careful. The prompt asks "Using ONLY supplied earnings call transcript and no outside information: On this call, does management describe that the company is NOW BEING ENTRUSTED WITH A MATERIALLY LARGER OR MORE CENTRAL CLASS OF WORK THAN IT HISTORICALLY RECEIVED — that is, does management convey that the engagements, projects, orders, mandates, or roles it is winning or performing have stepped up in scale or consequence relative to what this company used to be given — and that this step-up is already visible in actual business being won or performed today?" This seems like a "yes" if management says something like "we are now being given bigger roles" etc. But transcript is about pharma results. There is no mention of "entrusted" or "customers" giving them larger work. They talk about "we have a broad front-line lung cancer program which we expanded and strengthened over the last several months. We have four combination front-line lung studies that are ongoing. These studies are designed with the optionality we build into all of our studies. We are committed to the development of the combination of Yervoy plus Opdivo." This is internal R&D, not customers entrusting them. They talk about "opportunity to play a meaningful role in the treatment of patients in the first-line lung cancer setting." That's future opportunity, not current business won. They talk about "commercial execution" and "growth" but not step-up in scale of engagements. Need answer NO. But let's thoroughly examine for any possible "entrusted" language.
NO Outside actors already moving: management's forward story is carried by at least two independent external parties whose
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the explanation for the company's business being "about to be meaningfully larger" is carried primarily by already-taken actions of external parties, with at least two separate external parties, and the reported numbers lag what those outsiders are doing, with management saying so. The transcript is about Bristol-Myers Squibb's Q4 2016 earnings call. The company discusses its performance, guidance, and various products. The question focuses on whether the forward story rests on external parties' already-taken actions. Key points: The company discusses Opdivo, Yervoy, Eliquis, etc. The forward story seems to be about growth in international business, particularly after price negotiations in France and Germany. They mention that they completed price negotiations and recognized revenue. They also mention the launch of new indications. However, the question is about "the company's business is about to be meaningfully larger" - is that explanation carried primarily by already-taken actions of external parties? And are there at least two separate external parties? Let's parse the transcript. Management talks about growth drivers. For example, Murdo Gordon discusses the I-O business in three components: U.S. lung, U.S. non-lung, and international. He mentions that in international, they have secured reimbursement and seen uptake. Specifically, they completed price negotiations for France and Germany, resulting in revenue recognition. That is an external action (government/health authority approving price). Also, they mention the launch of head-and-neck and bladder approvals. But those are company actions (getting approvals). The external parties here are the regulatory bodies and payers. But the question is about "already-taken actions of external parties" that are causing the business to be meaningfully larger. The company is not saying that external parties have already committed to large orders that will ramp up. Instead, they are talking about their own commercial execution, their own pipeline, and their own expectations. The forward story seems to be about their own initiatives, like defending their position, launching new indications, and advancing their pipeline. The external parties (like payers) are mentioned as having completed negotiations, but that is more of a routine business activity, not a step change.
NO The new engine is already turning: a recently live driver is producing real business now, and management says the report
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management identifies a specific newer driver of business that is already producing real business now and that the reported period caught only the start of it. The transcript discusses Opdivo, Yervoy, Eliquis, etc. But the question asks for a specific newer driver. Possibly the international business for Opdivo? Or the launch of head-and-neck indication? Or bladder approval expected? But bladder is not yet approved. The international business for Opdivo: they mention completing price negotiations in France and Germany, recognizing revenue, and expect continued growth. But is that a "newer driver"? It's part of existing business. The question asks for a specific identifiable thing such as a new contract, program, product, etc. Look for something that is already producing and early stage. For example, they mention "recently launched head-and-neck indication" and "expected bladder approval" but bladder not yet. Head-and-neck is launched. But is it described as early? They say "very early launch, but execution looks good in head-and-neck." That could be a driver. But is it significant enough? They mention it as part of non-lung business. Also they mention "our recently launched head-and-neck indication" in Giovanni's remarks. But they don't quantify or say it's a major driver. They also mention "we are also getting some non-promoted sales in small-cell lung cancer" but that's off-label. Another possibility: The international business for Opdivo. They say "our teams have done a great job with access and reimbursement. You've seen that in our full-year results. Specifically in the quarter, we completed price negotiations for France and Germany. Overall, I expect to see continued growth internationally in 2017." That is about existing business expanding. Not necessarily a new driver. The question asks for a specific newer driver that is already producing real business now and that the reported period caught only the start. For example, a new product launch, a new indication, a new market entry. The head-and-neck indication is a new launch. They say "very early launch" and "execution looks good." That suggests it's early. But is it a major driver? They don't give numbers. Also they mention "expected bladder approval" but that's not yet. Another possibility: The Opdivo/Yervoy combination in melanoma? That's existing.
Showing the latest 18 of 229 archived research questions.
These archived questions are separate from the newer 500-check scan above.
BMY call history
Open a quarter only when you want its detailed evidence.
B Q1 2026 · Solid call · 2026-04-30Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
B Q4 2025 · Solid call · 2026-02-05Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
C Nov 2025 · Caution · 2025-11-27Management raised guidance against accelerating demand. The delivery was rich in specifics, frequently evasive.
View the 20 core call-quality checks
B Q1 2025 · Solid call · 2025-04-24Management raised guidance against accelerating demand. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
B Q4 2024 · Solid call · 2025-02-06Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
View the 20 core call-quality checks
B+ Q3 2024 · Strong call · 2024-10-31Management raised guidance against accelerating demand. The delivery was unusually candid, rich in specifics, relaxed under questioning.
View the 20 core call-quality checks
C Q2 2024 · Caution · 2024-07-26Management raised guidance against accelerating demand. The delivery was rich in specifics.
View the 20 core call-quality checks
View 35 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 2024-04-29 | D | maintained | mixed | contracting | 7/9 | 3/9 |
| Q4 2023 | 2024-02-02 | C+ | maintained | mixed | contracting | 7/9 | 4/9 |
| Q3 2023 | 2023-10-26 | C+ | raised | mixed | contracting | 7/9 | 3/9 |
| Q2 2023 | 2023-07-27 | D | lowered | mixed | stable | 7/9 | 3/9 |
| Q1 2023 | 2023-04-27 | C+ | maintained | accelerating | stable | 7/9 | 3/9 |
| Q4 2022 | 2023-02-02 | C | maintained | accelerating | contracting | 6/9 | 4/9 |
| Q3 2022 | 2022-10-26 | C+ | maintained | accelerating | contracting | 6/9 | 3/9 |
| Q2 2022 | 2022-07-27 | C | maintained | accelerating | stable | 7/9 | 5/9 |
| Q1 2022 | 2022-04-29 | D | lowered | mixed | stable | 6/9 | 4/9 |
| Q4 2021 | 2022-02-04 | C | maintained | accelerating | stable | 6/9 | 5/9 |
| Q3 2021 | 2021-10-27 | C+ | raised | accelerating | stable | 6/9 | 4/9 |
| Q2 2021 | 2021-07-28 | C | maintained | accelerating | contracting | 6/9 | 4/9 |
| Q1 2021 | 2021-04-29 | C | maintained | stable | stable | 6/9 | 4/9 |
| Q4 2020 | 2021-02-04 | C+ | raised | accelerating | stable | 6/9 | 4/9 |
| Q3 2020 | 2020-11-05 | C+ | raised | accelerating | stable | 6/9 | 4/9 |
| Q2 2020 | 2020-08-06 | C+ | raised | stable | stable | 6/9 | 4/9 |
| Q1 2020 | 2020-05-07 | C | maintained | mixed | stable | 6/9 | 4/9 |
| Q4 2019 | 2020-02-06 | C | maintained | mixed | expanding | 7/9 | 4/9 |
| Q3 2019 | 2019-10-31 | D | raised | mixed | stable | 6/9 | 6/9 |
| Q2 2019 | 2019-07-25 | D | maintained | mixed | stable | 7/9 | 4/9 |
| Q1 2019 | 2019-04-25 | D | maintained | mixed | contracting | 6/9 | 4/9 |
| Q4 2018 | 2019-01-24 | F | maintained | stable | expanding | 6/9 | 5/9 |
| Q3 2018 | 2018-10-25 | D | raised | stable | stable | 6/9 | 5/9 |
| Q2 2018 | 2018-07-26 | B | raised | accelerating | stable | 7/9 | 4/9 |
| Q1 2018 | 2018-04-26 | D | raised | accelerating | contracting | 6/9 | 5/9 |
| Q4 2017 | 2018-02-05 | D | maintained | accelerating | contracting | 6/9 | 5/9 |
| Q3 2017 | 2017-10-26 | D | raised | accelerating | contracting | 6/9 | 6/9 |
| Q2 2017 | 2017-07-27 | F | raised | stable | contracting | 5/9 | 7/9 |
| Q1 2017 | 2017-04-27 | C | raised | accelerating | contracting | 6/9 | 4/9 |
| Q4 2016 | 2017-01-26 | F | lowered | mixed | contracting | 5/9 | 7/9 |
| Q3 2016 | 2016-10-27 | C | raised | accelerating | contracting | 6/9 | 3/9 |
| Q2 2016 | 2016-07-28 | B+ | raised | accelerating | contracting | 7/9 | 2/9 |
| Q2 2021 | 2016-06-07 | C | maintained | accelerating | contracting | 6/9 | 4/9 |
| Q1 2016 | 2016-04-28 | C+ | raised | accelerating | contracting | 6/9 | 4/9 |
| Q4 2015 | 2016-01-28 | C+ | maintained | accelerating | contracting | 7/9 | 3/9 |